检索

标题
作者
Primary resistance to anti-HER2 therapy: mechanisms of development and ways to overcome
Dashyan G., Dzhelialov E., Konstantinova V., Gronskaya Y., Murskikh A., Akhmedov R., Tyusenko A., Olchonova A., Dyakonenko Z., Sereda O., Belousov A.
NOVYE PERSPEKTIVNYE PREPARATY DLYa LEChENIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Gorbunova V.
De-escalation and escalation of treatment of patients with HER2-positive breast cancer
Semiglazov V., Semiglazov V., Nikolaev K., Komyakhov A., Semiglazova T., Paltoev R., Donskikh R., Tseluyko A., Artemyeva A., Bashlyk V., Miryusupova G., Dashyan G.
PLACE OF LAPATINIB IN THE THERAPY OF HER2-POSITIVE BREAST CANCER
Zhukova L., Ganshina I., Zaitsev V., Stepanchenko M.
ChETYRE ASPEKTA AD\"YuVANTNOY TARGETNOY TERAPII HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Semiglazov V., Semiglazov V.
NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
Semiglazov V., Semiglazov V., Dashyan G., Krivorotko P., Nikolaev K., Semiglazova T., Komyakhov A., Bessonov A., Donskikh R., Paltuev R., Zernov K.
Herceptin in the treatment of disseminated HER2-positive gastric cancer. Clinical case of successful treatment of elderly patient
Besova N., Khokhlova S., Gorbunova V.
Klinicheskiy sluchay uspeshnogo lecheniya HER-pozitivnogo disseminirovannogo raka zheludka s polnym i prodolzhitel'nym effektom
Vakhabova Y., Filimonyuk A., Lodygina K., Vorontsova K., Lichinitser M.
Adjuvant therapy with trastuzumab for early-stage breast cancer: 12 or 24 months (based on ESMO data, Vienna, october, 2012)
Zhukova L., Lichinitser M.
Kadsila (trastuzumab emtanzin, T-DM1): pervyy kon\"yugat antitela i khimiopreparata v lechenii HER2-polozhitel'nogo raka molochnoy zhelezy
Borisova E., Gutorov S., Lichinitser M.
Opyt primeneniya trastuzumaba v respublike Bashkortostan
Sakaeva D., Kunafina R., Popova E.
Dual HER2 blockade with pertuzumab+trastuzumab on the eve of a new era in the treatment of HER2-positive breast cancer
Zhukova L., Artamonova E., Ganshina I., Kolyadina I., Vorontsova K., Sekhina O., Grechukhina K.
Pertuzumab - novyy vzglyad na HER2-polozhitel'nyy metastaticheskiy rak molochnoy zhelezy
Gan'shina I., Zhukova L., Tyurin I.
TARGETED THERAPY AFTER PROGRESSION OF HER-2-POSITIVE BREAST CANCER
Tat'yana Y., Semiglazov V., Larisa V., Chubenko V., Nikita V., Fedor V., Latipova D., Mikhail L., Semiglazova T., Semiglazov V., Filatova L., Chubenko V., Brejnev N., Moiseenko F., Latipova D., Gershanovich M.
Trastuzumab emtanzin in the treatment of HER2-positive metastatic breast cancer in patients with visceral crisis
Vladimirova L., Popova I., Abramova N., Storozhakova A., Tikhanovskaya N., Novoselova K., Lyanova A., Ryadinskaya L., Yezhova M., Teplyakov M.
LAPATINIB PRI RAKE MOLOChNOY ZhELEZY
Fray I., Perevodchikova N.
TARGET THERAPY HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES: NEW PROSPECTS FOR TREATMENT
Yu Semiglazova T., Filatova L., Kh Latipova D., Gershanovich M., Semiglazova T., Filatova L., Khamidovna L., Gershanovich M.
Example of the integrated approach to treatment of the patient with disseminated stomach cancer taking into account of modern clinical trends
Besova N., Trusilova E., Obarevich E., Tupitsyn N., Gorbunova V., Davydov M., Drobot N., Perfiliev B., Malikhova O.
DVOYNAYa BLOKADA HER2-PETsEPTOPA - NOVOE NAPRAVLENIE V LEChENII RAKA MOLOChNOY ZhELEZY S GIPEREKSPRESSIEY HER2
Gan'shina I., Lubennikova E., Zhukova L.
ADJUVANT ANTI-HER2 THERAPY FOR BREAST CANCER
Semiglazov V., Semiglazov V., Ivanov V., Bessonov A., Shchedrin D., Zhiltsova Y., Dashyan G., Paltuev R., Semiglazova T., Penkov K., Vasilyev A., Semiglazov V., Semiglazov V., Ivanov V., Bessonov A., Shchedrin D., Zhil'tsova E., Dashyan G., Paltuev R., Semiglazova T., Pen'kov K., Vasil'ev A.
1 - 20 的 20 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##